Literature DB >> 27760913

Is the Effect of Omega-3 Polyunsaturated Fatty Acids Dependent on Life-Style, Severity of Disease, and Use of Concomitant Medications?

Ichiro Tatsuno1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27760913      PMCID： PMC5383541          DOI： 10.5551/jat.ED063

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  11 in total

1.  n-3 fatty acids in patients with multiple cardiovascular risk factors.

Authors:  Maria Carla Roncaglioni; Massimo Tombesi; Fausto Avanzini; Simona Barlera; Vittorio Caimi; Paolo Longoni; Irene Marzona; Valentina Milani; Maria Giuseppina Silletta; Gianni Tognoni; Roberto Marchioli
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

Review 2.  Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia.

Authors:  Ichiro Tatsuno
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-10-16

Review 3.  Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review.

Authors:  Ethan M Balk; Alice H Lichtenstein; Mei Chung; Bruce Kupelnick; Priscilla Chew; Joseph Lau
Journal:  Atherosclerosis       Date:  2005-08-09       Impact factor: 5.162

4.  Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos.

Authors:  H O Bang; J Dyerberg; A B Nielsen
Journal:  Lancet       Date:  1971-06-05       Impact factor: 79.321

5.  n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

Authors:  Jackie Bosch; Hertzel C Gerstein; Gilles R Dagenais; Rafael Díaz; Leanne Dyal; Hyejung Jung; Aldo P Maggiono; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf
Journal:  N Engl J Med       Date:  2012-06-11       Impact factor: 91.245

6.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

Authors: 
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

7.  Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized double-blind (ORD) study.

Authors:  Ichiro Tatsuno; Yasushi Saito; Kentarou Kudou; Jun Ootake
Journal:  J Clin Lipidol       Date:  2013-02-04       Impact factor: 4.766

8.  Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Authors:  Luigi Tavazzi; Aldo P Maggioni; Roberto Marchioli; Simona Barlera; Maria Grazia Franzosi; Roberto Latini; Donata Lucci; Gian Luigi Nicolosi; Maurizio Porcu; Gianni Tognoni
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

9.  Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects.

Authors:  T Terano; A Hirai; T Hamazaki; S Kobayashi; T Fujita; Y Tamura; A Kumagai
Journal:  Atherosclerosis       Date:  1983-03       Impact factor: 5.162

10.  A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients.

Authors:  Ta-Chen Su; Juey-Jen Hwang; Kuo-Chin Huang; Fu-Tien Chiang; Kuo-Liong Chien; Kuo-Yang Wang; Min-Ji Charng; Wei-Chuan Tsai; Lian-Yu Lin; Runar Vige; José Emilio Ruiz Olivar; Chuen-Den Tseng
Journal:  J Atheroscler Thromb       Date:  2016-09-06       Impact factor: 4.928
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.